Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 3
1962 1
1965 2
1966 4
1967 6
1968 3
1969 4
1970 3
1971 11
1972 8
1973 4
1974 6
1975 1
1976 4
1977 7
1978 8
1979 11
1980 9
1981 11
1982 14
1983 14
1984 13
1985 13
1986 13
1987 9
1988 12
1989 8
1990 13
1991 25
1992 25
1993 21
1994 17
1995 25
1996 19
1997 23
1998 27
1999 32
2000 25
2001 15
2002 44
2003 33
2004 26
2005 34
2006 32
2007 40
2008 54
2009 55
2010 58
2011 80
2012 102
2013 111
2014 99
2015 136
2016 205
2017 213
2018 193
2019 79
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

1,861 results
Results by year
Filters applied: . Clear all
Page 1
Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance.
Aubé C, et al. Diagn Interv Imaging 2017 - Review. PMID 28461073 Free article.
Although biological scores and elastography continue to yield the best results, imaging retains a crucial role in the diagnosis of liver fibrosis and cirrhosis. ...Second, imaging could lead to discovery of nonsymptomatic fibrosis or cirrhosis, with an estimated prevalence of 0.5-2.8% in the population. ...
Although biological scores and elastography continue to yield the best results, imaging retains a crucial role in the diagnosis of …
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.
Younossi ZM, et al. Hepatology 2018. PMID 29222917 Free PMC article.
Nonalcoholic fatty liver disease (NAFLD) is a spectrum comprised of isolated steatosis, nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. The majority of NAFLD subjects do not have NASH and do not carry a significant risk for liver-related adverse outcomes (cirrhosis and mortality). ...
Nonalcoholic fatty liver disease (NAFLD) is a spectrum comprised of isolated steatosis, nonalcoholic steatohepatitis (NASH), advanced …
Liver fibrosis: Review of current imaging and MRI quantification techniques.
Petitclerc L, et al. J Magn Reson Imaging 2017 - Review. PMID 27981751
All causes of chronic liver disease may lead to fibrosis and cirrhosis. The severity of liver fibrosis influences the decision to treat or the need to monitor hepatic or extrahepatic complications. ...IMAGING 2017;45:1276-1295....
All causes of chronic liver disease may lead to fibrosis and cirrhosis. The severity of liver fibrosis influences the d …
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis.
Xiao G, et al. Hepatology 2017 - Review. PMID 28586172
Many noninvasive methods for diagnosing liver fibrosis (LF) have been proposed. To determine the best method for diagnosing LF in nonalcoholic fatty liver disease (NAFLD), we conducted a systemic review and meta-analysis to compare the performance of aspartate aminotransferase to platelets ratio index (APRI), fibrosis-4 index (FIB-4), BARD score, NAFLD fibrosis score (NFS), FibroScan, shear wave elastography (SWE), and magnetic resonance elastography (MRE) for diagnosing LF in NAFLD. ...CONCLUSION: MRE and SWE may have the highest diagnostic accuracy for staging fibrosis in NAFLD patients. Among the four noninvasive simple indexes, NFS and FIB-4 probably offer the best diagnostic performance for detecting AF. ...
Many noninvasive methods for diagnosing liver fibrosis (LF) have been proposed. To determine the best method for diagnosing LF in non …
Liver Fibrosis Quantification by Magnetic Resonance Imaging.
Petitclerc L, et al. Top Magn Reson Imaging 2017 - Review. PMID 28858038 Free PMC article.
Hence, there has been an effort to develop noninvasive imaging techniques for diagnosis, staging, and monitoring of liver fibrosis. ...This article will review the MRI techniques used in liver fibrosis staging, their advantages and limitations, and diagnostic performance. ...
Hence, there has been an effort to develop noninvasive imaging techniques for diagnosis, staging, and monitoring of liver fibr …
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD.
Tapper EB and Loomba R. Nat Rev Gastroenterol Hepatol 2018 - Review. PMID 29463906
It is crucial that patients with NAFLD receive an assessment for their risk of advanced fibrosis, which increases the risk of hepatocellular carcinoma and other complications of cirrhosis. ...Given patients' preference to avoid liver biopsy, noninvasive alternatives to assess liver fibrosis are in high demand. The most accurate noninvasive methods are based on liver elastography. ...
It is crucial that patients with NAFLD receive an assessment for their risk of advanced fibrosis, which increases the risk of hepatocellular …
Imaging biomarkers in liver fibrosis.
Berzigotti A, et al. Radiologia 2018 - Review. PMID 29108657 Free article.
The degree of liver fibrosis determines the prognosis and therapeutic options in this population. Liver biopsy represents the reference standard for fibrosis staging. ...This article reviews the different acquisition techniques and image processing methods currently used in the evaluation of liver fibrosis, focusing on their diagnostic performance, applicability and clinical value. ...
The degree of liver fibrosis determines the prognosis and therapeutic options in this population. Liver biopsy represents the …
Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.
Cassinotto C, et al. Hepatology 2016 - Clinical Trial. PMID 26659452
Nonalcoholic fatty liver disease (NAFLD) has become a major public health issue. The goal of this study was to assess the clinical use of liver stiffness measurement (LSM) evaluated by supersonic shear imaging (SSI), FibroScan, and acoustic radiation force impulse (ARFI) in a cohort of NAFLD patients who underwent liver biopsy. ...LSM was assessed by SSI, FibroScan (M probe), and ARFI within two weeks prior to liver biopsy. Calculations of the area under the receiver operating curve (AUROC) were performed and compared for the staging of liver fibrosis. ...
Nonalcoholic fatty liver disease (NAFLD) has become a major public health issue. The goal of this study was to assess the clinical us …
[Diagnostic value of endoscopic ultrasonography, fibroscan, acoustic radiation pulse imaging, serological index, and their combination for early stage liver cirrhosis].
Tu CH, et al. Zhonghua Gan Zang Bing Za Zhi 2019. PMID 31594079 Chinese.
Objective: To investigate the diagnostic value of endoscopic ultrasonography (EUS), Fibroscan, acoustic radiation force impulse (ARFI), and aspartate aminotransferase-to-platelet ratio (APRI) and their combination for early stage liver cirrhosis. ...Conclusion: The combination of EUS, LSM and ARFI had a superior diagnostic value for early stage liver cirrhosis, and may improve the diagnosis rate and reduce the misdiagnosis rate....
Objective: To investigate the diagnostic value of endoscopic ultrasonography (EUS), Fibroscan, acoustic radiation force impulse (ARFI …
Imaging of Hepatic Fibrosis.
Mathew RP and Venkatesh SK. Curr Gastroenterol Rep 2018 - Review. PMID 30159792
PURPOSE OF REVIEW: The purpose of this review is to discuss the current imaging techniques for non-invasive assessment of liver fibrosis (LF). ...Other imaging methods including diffusion-weighted imaging (DWI), hepatocellular contrast-enhanced (HCE) MRI, T1 relaxometry, T1ρ imaging, textural analysis, liver surface nodularity, susceptibility-weighted imaging, and perfusion imaging are promising but need further evaluation and clinical validation. ...
PURPOSE OF REVIEW: The purpose of this review is to discuss the current imaging techniques for non-invasive assessment of liver
1,861 results
Jump to page
Feedback